Functional Skills
Genetics
Strategic Planning
Operations Management
Marketing Analytics
Forecasting / Projections
Brand Strategy
Commercial Strategy
Competitive Landscaping
Customer Segmentation
Gene Therapy
Go-to-market Strategy
Business Intelligence
Indication Prioritization
Patient Journey
Launch Planning & Preparation
Software Skills
Microsoft Office
Smartsheet
Google Sheets
Google Surveys
Qualtrics
Sector Experience
Healthcare
Life Sciences & Pharma
Notable Clients
Amgen
Denali Therapeutics
Novartis
Orca Bio
Whitehawk Therapeutics
Experience
LifeSci Consulting
Management Consulting
Principal
1/2022 - Present
Led, managed, and delivered a range of commercial strategy projects for clients across biopharma
Corsica Life Sciences
Management Consulting
Principal
10/2015 - 12/2021
Led, managed, and delivered a range of commercial strategy projects for clients across biopharma
Campbell Alliance/Syneos Health
Management Consulting
Senior Consultant
6/2013 - 9/2015
Delivered commercial strategy and pricing and market access engagements for commercial biopharma
UCLA
Other
POSTDOCTORAL SCHOLAR, NEUROLOGY
1/2010 - 6/2013
Conducted research the lab of Dr. Daniel Geschwind, a pioneer of gene expression network analysis in characterizing neurodevelopmental and neurodegenerative disease. Studied novel causes and mechanisms of neurodegenerative disease, contributing molecular biology and genetics expertise, and developing computational biology skills including programming. Work was multidisciplinary including dry (genome level expression data and network analysis), and wet (tissue culture, virus preparation, tissue staining, microscopy) lab techniques.
• Miller J, Woltjer R, Goodenbour J, Horvath S, Geschwind D, "Genes and pathways underlying regional and cell type changes in Alzheimer's disease." Genome Med, 2013. 5(5): 48.
• Miller J, Woltjer R, Goodenbour J, Horvath S, Geschwind D, "Genes and pathways underlying regional and cell type changes in Alzheimer's disease." Genome Med, 2013. 5(5): 48.